Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H24N2O |
Molecular Weight | 356.4602 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)NC2=C3C=CC=CC3=CC=C2)C4=C1C=CC=C4
InChI
InChIKey=GWCQNKRMTGVYIZ-UHFFFAOYSA-N
InChI=1S/C24H24N2O/c1-2-3-8-16-26-17-21(20-13-6-7-15-23(20)26)24(27)25-22-14-9-11-18-10-4-5-12-19(18)22/h4-7,9-15,17H,2-3,8,16H2,1H3,(H,25,27)
Molecular Formula | C24H24N2O |
Molecular Weight | 356.4602 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21885167 |
10.0 nM [EC50] | ||
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21885167 |
100.0 nM [Ki] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sun Dec 18 04:56:42 UTC 2022
by
admin
on
Sun Dec 18 04:56:42 UTC 2022
|
Record UNII |
7FVT9P642K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-NNE1
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1338925-11-3
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY | |||
|
DTXSID50716467
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY | |||
|
54752945
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY | |||
|
NNE1
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY | NNE1 (also known as NNEI, MN-24 and AM-6527) is an indole-based synthetic cannabinoid, representing a molecular hybrid of APICA and JWH-018. It was invented by Abbott and has a CB1 receptor pEC50 of 8.9 (i.e. EC50 of approximately 1nM) with around 80x selectivity over the related CB2 receptor. It is suspected that metabolic hydrolysis of the amide group of NNE1 may release 1-naphthylamine, a known carcinogen, given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, and NNE1 was banned in New Zealand in 2012 as a temporary class drug to stop it being used as an ingredient in then-legal synthetic cannabis products.(3) NNE1 was subsequently found to be responsible for the death of a man in Japan in 2014. | ||
|
7FVT9P642K
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY | |||
|
MN-24
Created by
admin on Sun Dec 18 04:56:42 UTC 2022 , Edited by admin on Sun Dec 18 04:56:42 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |